| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/07/1997 | DE19603984A1 Granulate von Triazinen Granules of triazines |
| 08/07/1997 | DE19603788A1 Preparation of concentrated plant extract, particularly from Harpagophytum procumbens |
| 08/07/1997 | DE19603649A1 Rekombinante Expression von S-Layer-Proteinen Recombinant expression of S-layer proteins |
| 08/07/1997 | DE19603510A1 Use of new and known terrecyclolic acid compounds (tri:cyclo:undecane(s)) |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | CA2279978A1 Antigenic modulation of cells |
| 08/07/1997 | CA2246419A1 Combination therapy method for treating cancer using edatrexate and a taxane derivative, e.g. paclitaxel |
| 08/07/1997 | CA2245718A1 Novel aromatic piperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions, and use thereof as drugs |
| 08/07/1997 | CA2245715A1 5.alpha.-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof |
| 08/07/1997 | CA2245529A1 Antidiabetic agents |
| 08/07/1997 | CA2245524A1 Antidiabetic agents |
| 08/07/1997 | CA2245165A1 Sensitization of her2/neu over-expressing cancer cells to chemotherapeutic drugs |
| 08/07/1997 | CA2245145A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | CA2245085A1 Protection of hemopoietic cells |
| 08/07/1997 | CA2244985A1 Antiglucocorticoid drug |
| 08/07/1997 | CA2244940A1 Novel piperidines derived from 1-/(piperazin-1-yl)aryl(oxy/amino)carbonyl/-4-aryl-piperidine as selective 5-ht1db receptor antagonists |
| 08/07/1997 | CA2244879A1 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 08/07/1997 | CA2244841A1 Combined radiotherapy and immunotherapy to treat cancer |
| 08/07/1997 | CA2244831A1 Method of treating diabetes and related disease states |
| 08/07/1997 | CA2244791A1 Method for inhibiting tumor cell growth |
| 08/07/1997 | CA2244746A1 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents |
| 08/07/1997 | CA2244728A1 Use of angiogenic lipids for vascularizing tissue |
| 08/07/1997 | CA2244727A1 Immunomodulatory methods using oligosaccharides |
| 08/07/1997 | CA2244411A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | CA2244203A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | CA2244199A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | CA2243849A1 Inhibitors of farnesyl-protein transferase |
| 08/07/1997 | CA2243507A1 Inhibitors of farnesyl-protein transferase |
| 08/07/1997 | CA2243320A1 Inhibitors of farnesyl-protein transferase |
| 08/07/1997 | CA2243272A1 Inhibitors of farnesyl-protein transferase |
| 08/07/1997 | CA2243191A1 Diagnostic method and apparatus |
| 08/07/1997 | CA2242753A1 Composition for transdermal delivery of drugs |
| 08/07/1997 | CA2221444A1 A method of making pharmaceutically active taxanes orally bioavailable |
| 08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
| 08/06/1997 | EP0787796A1 Protective epitopes from adenylate cyclase-hemolysin(AC-Hly) and their use for treatment or prevention of Bordetella infections |
| 08/06/1997 | EP0787739A1 Anti-adhesive piperidine and pyrollidine -carboxylic acids |
| 08/06/1997 | EP0787729A2 A process for the manufacture of imidazodiazepine derivatives |
| 08/06/1997 | EP0787726A1 Novel compound, process for producing the same, and antitumor agent |
| 08/06/1997 | EP0787725A1 Quinoline derivative |
| 08/06/1997 | EP0787724A1 Novel intermediate for production and process for producing pyridine derivative |
| 08/06/1997 | EP0787723A1 Cyclopropachromenecarboxylate derivatives |
| 08/06/1997 | EP0787722A1 Substituted quinazoline derivatives |
| 08/06/1997 | EP0787717A1 Substituted diaryl dicarboxylic acid diguanidines, process for their preparation, their use as inhibitors of the Na+/H+ exchange as well as medicament or diagnostic agent containing them |
| 08/06/1997 | EP0787715A1 Process for the optical resolution of tramadol |
| 08/06/1997 | EP0787494A1 Remedy for diseases caused by infection with helicobacter |
| 08/06/1997 | EP0787492A1 Use of nitroxides and oxazolidines for protection against ionising radiation and oxidative stress |
| 08/06/1997 | EP0787491A1 Preventive and remedy for type i allergic diseases |
| 08/06/1997 | EP0787490A1 A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus |
| 08/06/1997 | EP0787489A2 Composition containing L-carnitine or alkanoyl-L-carnitine and hydroxycitric acid or pantothenic acid |
| 08/06/1997 | EP0787488A1 Percutaneously absorbable patch |
| 08/06/1997 | EP0787487A1 Pharmaceutical granulates containing an intragranular disintegrant |
| 08/06/1997 | EP0787206A1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS |
| 08/06/1997 | EP0787142A1 Neurturin and related growth factors |
| 08/06/1997 | EP0787141A2 Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process |
| 08/06/1997 | EP0787135A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 08/06/1997 | EP0787133A1 Tricyclic spiro compounds process for their preparation and their use as 5ht1d receptor antagonists |
| 08/06/1997 | EP0787132A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
| 08/06/1997 | EP0787131A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 08/06/1997 | EP0787130A1 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents |
| 08/06/1997 | EP0787127A1 5-lipoxygenase inhibitors |
| 08/06/1997 | EP0787126A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 08/06/1997 | EP0787122A2 Calcium receptor-active compounds |
| 08/06/1997 | EP0787121A1 Legionella specific antibiotic, a microorganism producing the antibiotic and a process for producing the same |
| 08/06/1997 | EP0787119A1 Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them |
| 08/06/1997 | EP0787011A1 Pharmaceutical compositions |
| 08/06/1997 | EP0787005A2 Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation |
| 08/06/1997 | EP0787003A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
| 08/06/1997 | EP0787002A1 Competitive progesterone antagonists for regulating female fertility as required |
| 08/06/1997 | EP0787001A1 Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis |
| 08/06/1997 | EP0787000A1 Quinazolinone pharmaceuticals and use thereof |
| 08/06/1997 | EP0786999A1 Combination method for acne treatment |
| 08/06/1997 | EP0786998A1 Use of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2] oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease |
| 08/06/1997 | EP0786997A1 Muscarine antagonists |
| 08/06/1997 | EP0786996A1 Cysteine protease and serine protease inhibitors |
| 08/06/1997 | EP0786995A1 Use of receptor potentiators |
| 08/06/1997 | EP0786994A2 Use of chloride channel blockers for reducing intraocular pressure |
| 08/06/1997 | EP0786992A2 Lta 4? hydrolase inhibitor pharmaceutical compositions and methods of use |
| 08/06/1997 | EP0786991A1 Polyamine compounds for treating vascular proliferative disorders |
| 08/06/1997 | EP0786990A1 Use of astaxanthin for retarding and ameliorating central nervous system and eye damage |
| 08/06/1997 | EP0786988A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs |
| 08/06/1997 | EP0786986A1 Pharmaceutical compositions |
| 08/06/1997 | EP0786984A1 Cosmetic composition |
| 08/06/1997 | EP0786946A1 Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed |
| 08/06/1997 | EP0786936A1 Method for reducing bacterial contamination in an aquaculture |
| 08/06/1997 | EP0731794B1 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders |
| 08/06/1997 | EP0724444B1 Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 08/06/1997 | EP0667774B1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system |
| 08/06/1997 | EP0664819B1 Chelating polymers |
| 08/06/1997 | EP0660698B1 Cosmetic or dermatologic composition containing at least one saponine of the ginsenoside type, and its applications particularly to hair care |
| 08/06/1997 | EP0615458B1 Method of reducing medical device related infections |
| 08/06/1997 | EP0594612B1 A substance for lowering high cholesterol level in serum and a method for preparing the same |
| 08/06/1997 | EP0593774B1 Food composition which inhibits formation of intestinal putrefaction product |
| 08/06/1997 | EP0593697B1 Mercapto-acetamide derivatives |
| 08/06/1997 | EP0577745B1 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents |
| 08/06/1997 | EP0559825B1 Device for treating tobacco addiction |
| 08/06/1997 | EP0540757B1 Water-based recording ink |
| 08/06/1997 | EP0512997B1 Process for the heterotrophic production of products with high concentrations of omega-3 highly unsaturated fatty acids |
| 08/06/1997 | EP0486499B1 Stable ascorbic acid compositions |
| 08/06/1997 | CN1156458A Spirostanyl glycosidal crystals |
| 08/06/1997 | CN1156456A 4-£2-amino-6-(cyclopropylamino)-9H-purin-9-yl|-2-cyclopentene-1-methanol succinate as antiviral agent |